Graphic Design Blog > Nitto Denko and Quark Pharmaceuticals to Enter Into Collaboration ...

[the technologeek] Nitto Denko Corporation, Japan’s leading diversified materials manufacturer and Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced the initiation of a collaboration and license agreement for the development of siRNA therapeutics for the treatment of fibrotic diseases …

Previous [Previous] Nitto Denko and Quark Pharma to collaborate on novel siRNA ...

Next [Next] Macromedia Flash 8: A Tutorial Guide » Free Full Downloa...

Some related posts from Technorati and Google.

[Silico Research] Nitto Denko and Quark Pharmaceuticals collaborate to develop siRNA ...: Nitto Denko and Quark Pharmaceuticals have announced the initiation of a collaboration and license agreement for the development of siRNA therapeutics for the treatment of fibrotic diseases. The collaboration is designed to develop siRNA drugs using Quark’s RNAi technologies and novel structures and Nitto Denko’s drug delivery technologies.

[Hormone Replacement Therapy News] Hormone Replacement Therapy News » Blog Archive » Nitto Denko ...: "Notwithstanding the provisions of section 106 and 106A, the fair use of a copyrighted work, including such use by reproduction in copies or phono-records or by any other means specified by that section, for purposes such as criticism, comment, news reporting, teaching (including multiple copies for classroom use), scholarship, or research, is not an infringement of copyright.

Reflected tags on Technorati: Blog, ,